The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases
- PMID: 12757706
- DOI: 10.1016/s0092-8674(03)00348-9
The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases
Abstract
In multiple sulfatase deficiency (MSD), a human inherited disorder, the activities of all sulfatases are impaired due to a defect in posttranslational modification. Here we report the identification, by functional complementation using microcell-mediated chromosome transfer, of a gene that is mutated in MSD and is able to rescue the enzymatic deficiency in patients' cell lines. Functional conservation of this gene was observed among distantly related species, suggesting a critical biological role. Coexpression of SUMF1 with sulfatases results in a strikingly synergistic increase of enzymatic activity, indicating that SUMF1 is both an essential and a limiting factor for sulfatases. These data have profound implications on the feasibility of enzyme replacement therapy for eight distinct inborn errors of metabolism.
Comment in
-
A major step on the road to understanding a unique posttranslational modification and its role in a genetic disease.Cell. 2003 May 16;113(4):421-2. doi: 10.1016/s0092-8674(03)00354-4. Cell. 2003. PMID: 12757700 Review.
Similar articles
-
Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme.Cell. 2003 May 16;113(4):435-44. doi: 10.1016/s0092-8674(03)00347-7. Cell. 2003. PMID: 12757705
-
Molecular and functional analysis of SUMF1 mutations in multiple sulfatase deficiency.Hum Mutat. 2004 Jun;23(6):576-81. doi: 10.1002/humu.20040. Hum Mutat. 2004. PMID: 15146462
-
A major step on the road to understanding a unique posttranslational modification and its role in a genetic disease.Cell. 2003 May 16;113(4):421-2. doi: 10.1016/s0092-8674(03)00354-4. Cell. 2003. PMID: 12757700 Review.
-
Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification.Int J Mol Sci. 2020 May 13;21(10):3448. doi: 10.3390/ijms21103448. Int J Mol Sci. 2020. PMID: 32414121 Free PMC article. Review.
-
Sulfatases and human disease.Annu Rev Genomics Hum Genet. 2005;6:355-79. doi: 10.1146/annurev.genom.6.080604.162334. Annu Rev Genomics Hum Genet. 2005. PMID: 16124866 Review.
Cited by
-
Entering the playing field: Therapy for multiple sulfatase deficiency.Mol Ther. 2024 Nov 6;32(11):3756-3757. doi: 10.1016/j.ymthe.2024.10.008. Epub 2024 Oct 30. Mol Ther. 2024. PMID: 39481371 No abstract available.
-
Bone marrow transplantation increases sulfatase activity in somatic tissues in a multiple sulfatase deficiency mouse model.Commun Med (Lond). 2024 Oct 25;4(1):215. doi: 10.1038/s43856-024-00648-y. Commun Med (Lond). 2024. PMID: 39448727 Free PMC article.
-
Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of multiple sulfatase deficiency.Mol Ther. 2024 Nov 6;32(11):3829-3846. doi: 10.1016/j.ymthe.2024.08.015. Epub 2024 Aug 22. Mol Ther. 2024. PMID: 39169621
-
The Genetics behind Sulfation: Impact on Airway Remodeling.J Pers Med. 2024 Feb 25;14(3):248. doi: 10.3390/jpm14030248. J Pers Med. 2024. PMID: 38540990 Free PMC article. Review.
-
A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiency.Mol Genet Metab. 2024 Feb;141(2):108116. doi: 10.1016/j.ymgme.2023.108116. Epub 2023 Dec 21. Mol Genet Metab. 2024. PMID: 38161139
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
